Search

The mechanisms governing a commonly observed seismic velocity drop in the cratonic lithosphere, referred to as the mid‐lithospheric discontinuity (MLD), have been widely debated. To identify the composition and seismic structure of MLDs, we have analyzed Sp receiver functions (SRF) and mantle xenocrysts for six regions across Australia. We utilize locations where seismic stations and kimberlite‐hosted mantle xenocrysts are both available, allowing for comparison between seismological and petrological constraints. Our results show negative SRF phases indicative of the MLD coincide with clinopyroxene‐depleted zones at 60–140 km depth. Clinopyroxenes with different chemical compositions across the MLD define a litho‐chemical discontinuity. Modeling and experimental data show that MLDs may be explained by modified lherzolite with 10%–20% modal pargasite. Pargasite MLDs may form when rising H2O‐bearing melts cross the amphibole dehydration curve and react with clinopyroxene in lherzolite. Because the amphibole dehydration curve is isobaric at 80–120 km, pargasite will be precipitated as horizontal channels. Plain Language Summary: Seismic imaging of Earth's lithosphere has revealed a seismic velocity drop at 60–120 km depth, termed the mid‐lithosphere discontinuity (MLD). The mechanisms governing the MLD have been extensively debated. To advance the understanding of the MLD we carried out an interdisciplinary study to investigate the seismic structure and composition of MLDs identified in the cratonic lithosphere of Australia. We integrated analysis of seismic converted signals from discontinuities recorded by permanent seismometers with geochemical data for kimberlite‐hosted mantle xenocrysts collected in the vicinity. The method allows direct comparison between seismological and petrological constraints. Our results suggest that the MLD comprises anomalously low abundances of clinopyroxene and separates geochemically distinct layers within the lithospheric mantle. Experimental results and modeling suggests that the observed decrease in seismic velocity and absence of clinopyroxene may relate to the formation of pargasite channels in modified lherzolite. Key Points: Sp receiver functions and mantle xenocrysts are used to study mid‐lithosphere discontinuities beneath Australian cratonsMid‐lithosphere discontinuity at 60–120 km depth corresponds with mantle xenocryst populations that are depleted in clinopyroxeneModeling and experimental data suggests the mid‐lithosphere discontinuity is caused by pargasite‐bearing lherzolite [ABSTRACT FROM AUTHOR]

Carbonatites and associated rocks are the main source of rare earth elements (REEs), metals essential to modern technologies. REE mineralization occurs in hydrothermal assemblages within or near carbonatites, suggesting aqueous transport of REE. We conducted experiments from 1200°C and 1.5 GPa to 200°C and 0.2 GPa using light (La) and heavy (Dy) REE, crystallizing fluorapatite intergrown with calcite through dolomite to ankerite. All experiments contained solutions with anions previously thought to mobilize REE (chloride, fluoride, and carbonate), but REEs were extensively soluble only when alkalis were present. Dysprosium was more soluble than lanthanum when alkali complexed. Addition of silica either traps REE in early crystallizing apatite or negates solubility increases by immobilizing alkalis in silicates. Anionic species such as halogens and carbonates are not sufficient for REE mobility. Additional complexing with alkalis is required for substantial REE transport in and around carbonatites as a precursor for economic grade-mineralization., (Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).)

Background. Local injections of Botulinum toxin type A (BTX-A) are an effective and safe solution for primary bilateral axillary hyperhidrosis. Traditional treatments are often ineffective and difficult to tolerate. This study was performed to assess the efficacy and safety of Botulinum toxin type A in the treatment of these diseases and to evaluate the reliability of patient's subjective rating in the timing of repeat injections. Methods. From 2007 to 2008, we included in the study and treated a total of 50 patients, and we used the Minor's iodine test and the hyperhidrosis diseases severity scale as initial inclusion criteria and also for evaluating the followup, comparing to patient's subjective rating. We used also a specific questionnaire to evaluate the level of pain, the onset of the effect, any eventual adverse effect of the treatment, the onset of compensatory hyperhidrosis, and the global grade of satisfaction. The data were analyzed using standard statistical methods. Results. 88% of patients were totally satisfied and all patients repeated the treatment during all the study. The symptom-free interval was in median 6 months with an average improving of HDSS of 1.5 points. In 86%, there was a complete accordance between the subjective patient's demand of the repetition of the treatment and the positivity to Minor test and HDSS. No major side effects happened. Conclusion. Local injections of Botulinum toxin type A (BTX-A) result in an effective and safe solution for bilateral axillary primary hyperhidrosis for the absence of significant morbidity, side effects, and lack of efficacy or duration. The only defects are the need of repetition of the treatment and relative costs.

Over a 3-year period, 67 patients of the Hospital of Pau (Pau, France), including 64 patients hospitalized in the adult intensive care unit (ICU), were colonized and/or infected by strains of Pseudomonas aeruginosa P12, resistant to all potentially active antibiotics except colistin. Most patients were mechanically ventilated and presented respiratory tract infections. Since cefepime and amikacin were the least inactive antibiotics by MIC determination, all ICU patients were treated with this combination, and most of them benefited. Cefepime-amikacin was found highly synergistic in vitro. Ribotyping and arbitrary primer-PCR analysis confirmed the presence of a single clonal isolate. Isoelectrofocusing revealed that the epidemic strain produced large amounts of the chromosomal cephalosporinase and an additional enzyme with a pI of 5.7, corresponding to PSE-1, as demonstrated by PCR and sequencing. Outer membrane protein profiles on sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed the absence of a ca. 46-kDa protein, likely to be OprD, and increased production of two ca. 49- and 50-kDa proteins, consistent with the outer membrane components of the efflux systems, MexAB-OprM and MexEF-OprN. Thus, we report here a nosocomial outbreak due to multiresistant P. aeruginosa P12 exhibiting at least four mechanisms of beta-lactam resistance, i.e., production of the penicillinase PSE-1, overproduction of the chromosomal cephalosporinase, loss of OprD, and overexpression of efflux systems, associated with a better activity of cefepime than ceftazidime.